The global erectile dysfunction treatment market Growth Accelerated by Rising Prevalence of Erectile Dysfunction

 

Erectile dysfunction treatment is essentially prescribed to patients suffering from erectile dysfunction, a condition in which a man finds it physically difficult to achieve or maintain an erection that is firm enough for sexual activity. Erectile dysfunction is prominently caused due to factors such as aging, diseases such as diabetes, obesity, kidney disease, arterial diseases, smoking, and excessive alcohol consumption. Non-pharmacological and pharmacological treatment options such as penile pumps, penile prostheses, PDE5 inhibitors, alprostadil injections, testosterone replacement therapy, penile rehabilitation following prostatectomy, and stem cell therapy are commonly prescribed for treating erectile dysfunction.

The global erectile dysfunction treatment market is estimated to be valued at US$ 4.54 Bn in 2023 and is expected to exhibit a CAGR of 7.6% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.

Market key trends:
One of the major trends driving the growth of the erectile dysfunction treatment market is the rising prevalence of erectile dysfunction across the globe. As per the estimates of Massachusetts Male Aging Study, the probability of complete erectile dysfunction is nearly 30% among men aged 40-70 years and more than 50% among men aged 70 years and above. Similarly, according to the projections of Ageing in Men's Health Study, nearly 40% of men will suffer from erectile dysfunction by 2030. Aging, diabetes, hypertension, obesity, smoking, and excessive alcohol consumption increase the risk of developing erectile dysfunction significantly. Rapid urbanization, changing lifestyle patterns, and increasing life expectancy are major demographic factors contributing to the rising prevalence of erectile dysfunction. This high prevalence rate has certainly increased the demand for effective erectile dysfunction treatment drugs and devices worldwide over the past few years.

Segment Analysis

The global erectile dysfunction treatment market is segmented based on drug type and distribution channel. Based on drug type, the market has been segmented into phosphodiesterase type 5 inhibitors, penile injections, urethral suppositories, and others. The phosphodiesterase type 5 inhibitors segment currently dominates the market owing to its high efficacy and minimal side effects. This segment is expected to continue its dominance over the forecast period due to strong product pipeline and upcoming patent expiries of major blockbuster drugs.

Key Takeaways

The global erectile dysfunction treatment market is expected to witness high growth over the forecast period. The market size for erectile dysfunction treatment is projected to reach US$ 4.54 Bn by 2023 growing at a CAGR of 7.6% during 2023-2030 forecast period.

Regional analysis

North America currently dominates the global erectile dysfunction treatment market owing to rising patient awareness levels regarding treatment options for erectile dysfunction. Moreover, strong presence of key market players in the region contributes to its large market share. The Asia Pacific region is expected to witness the fastest growth over the forecast period driven by improving healthcare infrastructure and increasing healthcare expenditure in major Asian countries like China and India.

Key players

Key players operating in the erectile dysfunction treatment market are Mangoceuticals, Inc, Futura Medical, CURE Pharmaceutical Holding Corp, Glenmark Pharmaceuticals Ltd, Mylan Pharmaceuticals Inc., Boston Scientific, Cipla Ltd, Pfizer Inc., Coloplast CORP, Eli Lily & Co, Gust Inc, Altera, Promedon, Dr. Reddys Laboratories Ltd, Bayer Pharma AG, and Reflexonic LLC. Mangoceuticals, Inc aims to become a leading brand in natural based erectile dysfunction treatments. Futura Medical is focused on launching its innovative erectile dysfunction treatment medication called MED3000.

Comments

Post a Comment

Popular posts from this blog

Unveiling Health Secrets: Exploring the Potential of Blood-Based Biomarkers

Image
  The human body is a complex and intricate system, often harboring subtle signs of its inner workings. One of the most promising avenues for unlocking these secrets lies within our bloodstream – a treasure trove of information encoded in the form of blood-based biomarkers. These biomarkers, measurable indicators present in the blood, hold the potential to revolutionize healthcare by providing early detection, accurate diagnosis, and personalized treatment approaches. Blood-based biomarkers encompass a wide range of molecules – from proteins and nucleic acids to metabolites and even circulating cells. Researchers have been diligently working to identify specific biomarkers associated with various diseases and conditions. For instance, elevated levels of certain proteins might point to cardiovascular diseases, while specific genetic material could indicate the presence of cancer. By analyzing these biomarkers, clinicians gain valuable insights into an individual's health status, en...
Read more

Revolutionizing Biology: Advancements in Single Cell Analysis Techniques

Image
  Single cell analysis has emerged as a groundbreaking technology that is revolutionizing the field of biology. Traditionally, biological studies were conducted on populations of cells, averaging out the heterogeneity present within them. However, the advent of single cell analysis has enabled scientists to delve into the complexity of individual cells, uncovering a wealth of previously inaccessible information. Advancements in single cell analysis techniques have paved the way for a deeper understanding of cellular heterogeneity, gene expression, and cellular behavior. One of the most remarkable techniques is single-cell RNA sequencing (scRNA-seq), which allows scientists to measure gene expression in individual cells. This breakthrough has led to the identification of rare cell types, understanding of cellular communication networks, and the discovery of novel biomarkers. Moreover, single cell imaging techniques, such as single cell fluorescence microscopy, have enabled research...
Read more

Medical Robots Market Poised to Grow Owing to Improving Healthcare Infrastructure

Image
 The Medical Robots Market is anticipated to witness robust growth due to rising healthcare spending across the globe. Medical robots are used to perform minimal invasive surgeries with greater accuracy and flexibility. Growing preference for Robot-Assisted Surgery (RAS) over conventional open surgeries due to benefits such as shorter recovery time and minimum operative scars has been augmenting demand for medical robots. Key functions include guiding and positioning surgical accessories like guide tubes in radiology and guiding catheter and wires in cardiology. With rising chronic disease prevalence associated with aging populations, the need for more surgical procedures is surging which requires precise action minimally invasive robotic systems can provide. The Global Medical Robots Market is estimated to be valued at US$ 11.47 Bn in 2024 and is expected to exhibit a CAGR of 16% over the forecast period 2023 to 2030. Key Takeaways: Key players operating in the Medical Robo...
Read more